• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Alzheimer's Disease Assessment Scale (ADAS).

作者信息

Mohs R C, Cohen L

出版信息

Psychopharmacol Bull. 1988;24(4):627-8.

PMID:3249763
Abstract
摘要

相似文献

1
Alzheimer's Disease Assessment Scale (ADAS).阿尔茨海默病评估量表（ADAS）。
Psychopharmacol Bull. 1988;24(4):627-8.
2
The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.阿尔茨海默病评估量表认知分量表（ADAS-Cog）土耳其语版本在轻度和中度阿尔茨海默病患者及正常受试者中的有效性和可靠性。
Int J Geriatr Psychiatry. 2006 Mar;21(3):259-65. doi: 10.1002/gps.1457.
3
[Spanish adaptation of the Alzheimer's disease assessment scale (ADAS)].[阿尔茨海默病评估量表（ADAS）的西班牙语改编版]
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1994 Mar-Apr;22(2):64-70.
4
The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.阿尔茨海默病评估工具使用达成共识的必要性：可行性研究（欧洲各地阿尔茨海默病中心的痴呆评估工具），欧洲阿尔茨海默病协会（EADC）的一项调查。
Int J Geriatr Psychiatry. 2005 Aug;20(8):744-8. doi: 10.1002/gps.1355.
5
Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID).阿尔茨海默病评估量表的跨国比较与验证：痴呆症工具欧洲协调项目（EURO-HARPID）的结果
Int J Geriatr Psychiatry. 2004 Jan;19(1):41-50. doi: 10.1002/gps.1035.
6
The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls.阿尔茨海默病评估量表 - 认知分量表：老年对照人群的常模数据
Alzheimer Dis Assoc Disord. 2004 Oct-Dec;18(4):236-40.
7
Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.阿尔茨海默病的临床试验。利用阿尔茨海默病注册协作组的数据计算阿尔茨海默病评估量表认知部分得分。
Psychopharmacol Bull. 2001 Spring;35(2):83-96.
8
A clinical rating scale for symptoms of psychosis in Alzheimer's disease.阿尔茨海默病精神病症状的临床评定量表。
Psychopharmacol Bull. 1985;21(1):101-4.
9
Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months.服用加兰他敏长达48个月的阿尔茨海默病患者的衰退模式及亚组证据。
Int J Geriatr Psychiatry. 2008 Feb;23(2):207-14. doi: 10.1002/gps.1864.
10
Outcome measures for probable vascular dementia and Alzheimer's disease with cerebrovascular disease.可能的血管性痴呆和伴有脑血管疾病的阿尔茨海默病的结局指标。
Int J Clin Pract Suppl. 2001 May(120):29-39.

引用本文的文献

1
Sodium benzoate treatment decreased amyloid beta peptides and improved cognitive function among patients with Alzheimer's disease: secondary analysis of a randomized clinical trial.苯甲酸钠治疗可降低阿尔茨海默病患者的β淀粉样肽水平并改善认知功能：一项随机临床试验的二次分析
Transl Psychiatry. 2025 Aug 5;15(1):264. doi: 10.1038/s41398-025-03492-3.
2
Multidomain Intervention Trial for Preventing Cognitive Decline among Older Adults with Type 2 Diabetes: J-MIND-Diabetes.多领域干预试验预防 2 型糖尿病老年患者认知能力下降：J-MIND-Diabetes。
J Prev Alzheimers Dis. 2024;11(6):1604-1614. doi: 10.14283/jpad.2024.117.
3
"Back to Braak": Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression.
“回归布拉克分期”：正中核及皮质下通路在阿尔茨海默病进展中的作用
J Prev Alzheimers Dis. 2024;11(4):1030-1040. doi: 10.14283/jpad.2024.42.
4
Shortening the Alzheimer's disease assessment scale cognitive subscale.缩短阿尔茨海默病评估量表认知分量表。
Eur Psychiatry. 2024 Feb 23;67(1):e19. doi: 10.1192/j.eurpsy.2024.14.
5
Relationship between cognitive function and phase angle measured with a bioelectrical impedance system.认知功能与生物电阻抗系统相位角的关系。
Eur Geriatr Med. 2024 Feb;15(1):201-208. doi: 10.1007/s41999-023-00894-8. Epub 2023 Nov 28.
6
Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease.内源性抗氧化剂可预测预后，并在治疗后增加：一项用于治疗阿尔茨海默病的苯甲酸盐剂量发现、随机、双盲、安慰剂对照试验。
Psychiatry Clin Neurosci. 2023 Feb;77(2):102-109. doi: 10.1111/pcn.13504. Epub 2022 Nov 24.
7
Effect of acupuncture with donepezil based on syndrome differentiation on cognitive function in patients with mild-to-moderate Alzheimer's disease: a study protocol for a multicenter randomized controlled trial.基于辨证取穴的针刺联合多奈哌齐对轻中度阿尔茨海默病患者认知功能的影响：一项多中心随机对照试验研究方案。
Trials. 2022 Aug 19;23(1):695. doi: 10.1186/s13063-022-06532-1.
8
Association between gait speed and errors on the Clock Drawing Test in older adults with mild cognitive impairment.老年人轻度认知障碍者步态速度与画钟测验错误的相关性。
Sci Rep. 2022 Jun 15;12(1):9929. doi: 10.1038/s41598-022-14084-2.
9
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer's disease.预测阿尔茨海默病淀粉样蛋白阳性患者的进展和认知能力下降。
Alzheimers Res Ther. 2021 Sep 6;13(1):151. doi: 10.1186/s13195-021-00886-5.
10
Factors associated with brain ageing - a systematic review.与大脑老化相关的因素——系统综述。
BMC Neurol. 2021 Aug 12;21(1):312. doi: 10.1186/s12883-021-02331-4.